Adverse Event Profile of Blinatumomab in Acute Lymphoblastic Leukemia
3 Visualizações
• 08/04/23
0
0
Embutir
administrator
Assinantes
In this segment, Raoul Tibes, MD, PhD, highlights common toxicities to be aware of in patients with acute lymphoblastic leukemia receiving blinatumomab therapy.
Mostre mais
Comentários do Facebook
SORT BY-
Melhores Comentários
-
Últimos Comentários